A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors

NCT06172309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: NTQ1062

Sponsor

Nanjing Chia-tai Tianqing Pharmaceutical